These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 11905036)
21. [Ion beam treatment: a new medical treatment system]. Hishikawa Y; Murakami M Gan To Kagaku Ryoho; 2008 Mar; 35(3):377-81. PubMed ID: 18347385 [TBL] [Abstract][Full Text] [Related]
22. [The present and future of heavy charged particle therapy]. Tsujii H Nihon Rinsho; 1996 Jan; 54(1):268-73. PubMed ID: 8587201 [TBL] [Abstract][Full Text] [Related]
23. High-dose proton therapy and carbon-ion therapy for stage I nonsmall cell lung cancer. Iwata H; Murakami M; Demizu Y; Miyawaki D; Terashima K; Niwa Y; Mima M; Akagi T; Hishikawa Y; Shibamoto Y Cancer; 2010 May; 116(10):2476-85. PubMed ID: 20225229 [TBL] [Abstract][Full Text] [Related]
24. Heidelberg Ion Therapy Center (HIT): Initial clinical experience in the first 80 patients. Combs SE; Ellerbrock M; Haberer T; Habermehl D; Hoess A; Jäkel O; Jensen A; Klemm S; Münter M; Naumann J; Nikoghosyan A; Oertel S; Parodi K; Rieken S; Debus J Acta Oncol; 2010 Oct; 49(7):1132-40. PubMed ID: 20831505 [TBL] [Abstract][Full Text] [Related]
25. Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study. Hata M; Tokuuye K; Kagei K; Sugahara S; Nakayama H; Fukumitsu N; Hashimoto T; Mizumoto M; Ohara K; Akine Y Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):786-93. PubMed ID: 17379439 [TBL] [Abstract][Full Text] [Related]
26. National Cancer Center has started proton therapy. Ogino T Jpn J Clin Oncol; 1999 Mar; 29(3):179. PubMed ID: 10225703 [No Abstract] [Full Text] [Related]
27. The M. D. Anderson proton therapy system. Smith A; Gillin M; Bues M; Zhu XR; Suzuki K; Mohan R; Woo S; Lee A; Komaki R; Cox J; Hiramoto K; Akiyama H; Ishida T; Sasaki T; Matsuda K Med Phys; 2009 Sep; 36(9):4068-83. PubMed ID: 19810479 [TBL] [Abstract][Full Text] [Related]
28. [Proton therapy on locally advanced cancer]. Fuwa N Gan To Kagaku Ryoho; 2009 Nov; 36(11):1788-90. PubMed ID: 19920378 [TBL] [Abstract][Full Text] [Related]
29. Physical specifications of clinical proton beams from a synchrotron. Arduini G; Cambria R; Canzi C; Gerardi F; Gottschalk B; Leone R; Sangaletti L; Silari M Med Phys; 1996 Jun; 23(6):939-51. PubMed ID: 8798164 [TBL] [Abstract][Full Text] [Related]
30. Proton Therapy Facility Planning From a Clinical and Operational Model. Das IJ; Moskvin VP; Zhao Q; Cheng CW; Johnstone PA Technol Cancer Res Treat; 2015 Oct; 14(5):635-41. PubMed ID: 24988058 [TBL] [Abstract][Full Text] [Related]
31. Physiologic reactions after proton beam therapy in patients with prostate cancer: significance of urinary autoactivation. Shimizu M; Sasaki R; Miyawaki D; Nishimura H; Demizu Y; Akagi T; Suga D; Sakamoto H; Murakami M; Sugimura K; Hishikawa Y Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):580-6. PubMed ID: 19735884 [TBL] [Abstract][Full Text] [Related]
32. Proton therapy for cancer treatment. Dinesh Mayani D J Oncol Pharm Pract; 2011 Sep; 17(3):186-90. PubMed ID: 20634263 [TBL] [Abstract][Full Text] [Related]
33. The development and clinical use of a beam ON-LINE PET system mounted on a rotating gantry port in proton therapy. Nishio T; Miyatake A; Ogino T; Nakagawa K; Saijo N; Esumi H Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):277-86. PubMed ID: 20005459 [TBL] [Abstract][Full Text] [Related]
34. Particle radiation therapy using proton and heavier ion beams. Schulz-Ertner D; Tsujii H J Clin Oncol; 2007 Mar; 25(8):953-64. PubMed ID: 17350944 [TBL] [Abstract][Full Text] [Related]
35. Is proton beam therapy cost effective in the treatment of adenocarcinoma of the prostate? Konski A; Speier W; Hanlon A; Beck JR; Pollack A J Clin Oncol; 2007 Aug; 25(24):3603-8. PubMed ID: 17704408 [TBL] [Abstract][Full Text] [Related]
36. Treatment of non-small cell lung cancer patients with proton beam-based stereotactic body radiotherapy: dosimetric comparison with photon plans highlights importance of range uncertainty. Seco J; Panahandeh HR; Westover K; Adams J; Willers H Int J Radiat Oncol Biol Phys; 2012 May; 83(1):354-61. PubMed ID: 21985941 [TBL] [Abstract][Full Text] [Related]
37. Prospective phase-II-study evaluating postoperative radiotherapy of cervical and endometrial cancer patients using protons - the APROVE-trial. Arians N; Lindel K; Krisam J; Herfarth K; Krug D; Akbaba S; Oelmann-Avendano J; Debus J Radiat Oncol; 2017 Nov; 12(1):188. PubMed ID: 29179751 [TBL] [Abstract][Full Text] [Related]
38. Proton beam therapy for childhood malignancies: status report. Timmermann B Klin Padiatr; 2010 May; 222(3):127-33. PubMed ID: 20514614 [TBL] [Abstract][Full Text] [Related]
39. Comparison of adverse effects of proton and X-ray chemoradiotherapy for esophageal cancer using an adaptive dose-volume histogram analysis. Makishima H; Ishikawa H; Terunuma T; Hashimoto T; Yamanashi K; Sekiguchi T; Mizumoto M; Okumura T; Sakae T; Sakurai H J Radiat Res; 2015 May; 56(3):568-76. PubMed ID: 25755255 [TBL] [Abstract][Full Text] [Related]
40. Phase II feasibility study of high-dose radiotherapy for prostate cancer using proton boost therapy: first clinical trial of proton beam therapy for prostate cancer in Japan. Nihei K; Ogino T; Ishikura S; Kawashima M; Nishimura H; Arahira S; Onozawa M Jpn J Clin Oncol; 2005 Dec; 35(12):745-52. PubMed ID: 16314345 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]